Delivery Order SPE2DB22D1017-SPE2DB25FG1BU
Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract, valued at $7,888.63, is structured as a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. Performance will be completed at the vendor's Conshohocken facility by the ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) with a ceiling value of $28,295.68. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 31, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,846.27 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 4, 2025, and performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under a larger contract vehicle, representing...
- AmerisourceBergen Drug Corp received a $2,369.47 delivery order award from the Defense Logistics Agency (DLA) on July 17, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL). This firm fixed-price, competitively awarded contract has an ultimate completion date of July 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) valued at $22,163.48. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of October 31, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency valued at $1,879.98 for Ozempic 0.25-0.5 mg/dose pens in 3 mL vials. The contract is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 28, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a $49,303 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with an ultimate completion date of September 22, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on August 20, 2025, valued at $9,486.77. The contract calls for the delivery of Ozempic 0.25–0.5 mg/dose pens (3 mL) to support federal medical supply requirements. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for ultimate completion by August 21, 2025, with...
- The Defense Logistics Agency awarded a $18,637.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL) on September 25, 2025, with an ultimate completion date of September 26, 2025. The contract was not set-aside and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with a contract ceiling value of $5,708.57 and an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery...